Compare INMB & BTTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INMB | BTTC |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 40.5M |
| IPO Year | 2019 | N/A |
| Metric | INMB | BTTC |
|---|---|---|
| Price | $2.03 | $2.74 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.30 | N/A |
| AVG Volume (30 Days) | 514.9K | ★ 2.7M |
| Earning Date | 10-30-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | $50,000.00 | ★ $2,719,480.00 |
| Revenue This Year | $173.21 | N/A |
| Revenue Next Year | $12,733.99 | N/A |
| P/E Ratio | ★ N/A | $3.82 |
| Revenue Growth | ★ 19.05 | 2.04 |
| 52 Week Low | $1.38 | $2.65 |
| 52 Week High | $11.64 | $39.00 |
| Indicator | INMB | BTTC |
|---|---|---|
| Relative Strength Index (RSI) | 59.52 | N/A |
| Support Level | $1.54 | N/A |
| Resistance Level | $2.30 | N/A |
| Average True Range (ATR) | 0.16 | 0.00 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 65.48 | 0.00 |
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
Black Titan Corp is engaged in software implementation and training. It provides consulting services and Human Resource and Payroll solutions.